Antineoplastics

Class at a glance

• Cancer drugs span cytotoxic + targeted therapy

Safety / monitoring

• Toxicity patterns differ more than efficacy class

Clinical role

• Selection is tumor-, stage- + biomarker-specific
• Targeted drugs exploit defined tumor pathways
• Immunotherapy releases antitumor immunity
• Do not generalize one cancer drug to another

Practical pearls

• Cytotoxics damage dividing cells broadly

Self-check

• What determines cancer-drug selection?
  Tumor, stage and biomarkers.
• What do cytotoxic cancer drugs damage broadly?
  Dividing cells.

Drugs in this class (52)

All drug classes · Open Antineoplastics in the interactive console ↗